Finally, with a deeper understanding of the molecular mechanisms underlying the formation, function, and therapeutic benefits of LMP2, PSME1, and PSME2 in the tumor, it may help guide NACI’s strategies for personalized precision medicine in the future. This evidence concerns the gene PSME2 and neoplasm.